Dr. Loh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Ventura Heart Institute
555 Marin Street, Suite 210
Thousand Oaks, CA 91360Phone+1 805-375-2501Fax+1 888-419-3230- Is this information wrong?
Summary
- Board certified internist & subspecialty certified cardiac specialist - emphasis preventive cardiology. Original cardiology consultant Doximity. Founded & directed the Ventura Heart Institute (education, research & preventive cardiovascular programs). Former Asst Prof Med UCLA School of Medicine & former Asst Clin Prof Med UC Irvine. Adjunct Lecturer, Stanford Univ School of Medicine. Member of 2 AI4H Working Groups (AI for symptom assessment) (AI for Clinical Evaluation)/World Health Organization. UC Berkeley (PBK as junior), MD UC San Francisco (Regents Scholar; AOA as junior), Internal Medicine Residency UCSF. Lipid research National Heart, Lung & Blood Institute at National Institutes of Health (NIH) in both intramural (Molecular Diseases/Lipid Metabolism Branch) & extramural (Cardiac Diseases Branch; Division of Heart and Vascular Diseases) divisions. Faculty in both Departments of Cardiology & Cardiac Surgery at Cedars-Sinai. Chaired HCA Los Robles Hospital IRB, founded BioEthics Committee, directed echocardiography lab. Principal investigator on over 160 cardiovascular clinical trials (primarily phase 1, 2, 3 trials). In 1987, he wrote a bespoke electronic health record system. Presenter at RAND, USC School of Business, UCLA Anderson School of Business, Mayo Clinic in Rochester MN, & at both UC Berkeley's Center for Information Technology Research in the Interest of Society & the School of Public Health & at Harvard School of Public Health. TEDx Lecturer (http://youtu.be/b51KhIy3cA0) on how medical advances are validated. Chief Medical Advisor to Confideo Lab/DoctorVirtualis (virtual reality), Advisor CV Services for MORE Health, Lead Contributor - Sermo's Cardiology Hub. Past Chair of Technology Committee of CA Chapter of ACC, Co-founder & CMO of Infermedica (artificial intelligence). Member - Global Panel/MIT Tech Review. CTeL Coalition Leadership (Telehealth4Ukraine.org). Advisor M7 Healthcare Accelerator (global incubator based in Silicon Valley).
Education & Training
- Cedars-Sinai Medical CenterFellowship, Cardiovascular Disease, 1979
- National Institutes of Health Clinical CenterResearch, 1974 - 1977
- University of California (San Francisco)Residency, Internal Medicine, 1974
- University of California (San Francisco) School of MedicineClass of 1972
Certifications & Licensure
- CA State Medical License 1974 - 2023
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Fellow, American College of Cardiology (FACC) American College of Cardiology
- Fellow, American Heart Association (Epidemiology & Prevention) American Heart Association
- Fellow, American College of Chest Physicians American College of Chest Physicians
- Join now to see all
Publications & Presentations
PubMed
- 9 citationsMoexipril versus captopril in patients with mild to moderate hypertension.Michael Stimpel, Brigitte Koch, Thomas Jansen, Alanna A.L. Fox, Irving Loh> ;Journal of Cardiovascular Pharmacology. 1996 Dec 1
- 10 citationsSecondary prevention and lipid lowering: Results and implicationsKatherine M. Detre, Robert I. Levy, Sheryl F. Kelsey, Stephen E. Epstein, John F. Brensike, Eugene R. Passamani, John M. Richardson, Irving K. Loh, Neil J. Stone, Robe...> ;American Heart Journal. 1985 Nov 1
- 327 citationsThe influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention S...Robert I. Levy, John F. Brensike, Stephen E. Epstein, S. F. Kelsey, Eugene R. Passamani, John M. Richardson, Irving K. Loh, Neil J. Stone, Robert F. Aldrich, James W. ...> ;Circulation. 1984 Feb 1
- Join now to see all
Journal Articles
- A Dose-Dependent Increase in Mortality with Vesnarinone Among Patients with Severe Heart Failure.Vesnarinone Trial Investigators, New England Journal of Medicine
- Hobbs RE. Results of the ATLAS Study – high or low doses of ACE inhibitors for heart failure?ATLAS Trial Investigators, Cleve Clin J Med
- Comparative Effects of Low and High Doses of the Angiotensin-Converting Enzyme Inhibitor, Lisinopril, on Morbidity and Mortality in Chronic Heart Failure.ATLAS Study Group, Circulation
- Join now to see all
Abstracts/Posters
- Moexipril Versus Captopril in Patients with Mild to Moderate Hypertension.Loh IK, Tenth Scientific Meeting of the American Society of Hypertension; New York Hilton/Towers, New York, NY
Lectures
- What You Need to Know About Preventing Cancer?Melissa Belle Ford, Director for Prevention and Early Detection, Univ of Texas, M.D. A...
- Relearning Optimism.Terry Paulson, Ph.D
- Television Report: The Prevention of Heart Disease -a five part series.the Ventura Heart Institute education and screening program; KEYT Evening News; Santa Barbara, CA
- Join now to see all
Other
- Innovations in pharmaceuticalsIK Loh, Street Journal
http://online.wsj.com/article/ - Radio Interview: Health Care Reform: Initiatives to reduce federal impediments to the delivery of health care.Loh IK
The White House, Washington - Risk Factors in Premature Coronary Disease (Interview by Deborah Norville)Loh IK, Guest
NBC Studios, New York
Authored Content
- ACC 2021: Convergence of Cardiovascular and Diabetic Therapies ContinueMay 2021
- Here's What ISCHEMIA Really MeansNovember 2019
- Here's What ISCHEMIA Really MeansNovember 2019
- We Don't Have to Just Accept Patients Taking Health SupplementsFebruary 2019
- We Don't Have to Just Accept Patients Taking Health SupplementsFebruary 2019
- Join now to see all
Press Mentions
- The Future of Cardio Care: Assessment, Genetics and AIJanuary 3rd, 2020
- Telemedicine and the Future of Healthcare DeliveryApril 28th, 2019
- Dr. Loh: How Clinical Researchers Handle Pauses in Vaccine TrialsNovember 1st, 2020
- Join now to see all
Committees
- Chair, Technology & Innovation Committee, California Chapter of American College of Cardiology 2019 - Present
- Member, Artificial Intelligence for Symptom Assessment; International Telecommunication Union; World Health Organization 2019 - Present
- Member, Executive Steering Committee of the National Health Policy Council 1993 - 1995
- Member, Amgen’s Institutional BioSafety Committee
- Member, State of California Department of Health Services Cardiovascular Disease Prevention Coalition
- Member, Manuscript Review Board and Ad Hoc Editor for the Journal of Clinical Outcomes Management
- Member, Expert Panel on Outcomes Evaluation and Research for the American Heart Association
- Member, Advisory Board Company/Cardiology Preeminence Roundtable based in Washington DC
- Executive Steering Committee member, West Lipid Association Board of Directors
- Charter Member, Lipidologists of Los Angeles
Research History
- Director & Principal InvestigatorVentura Heart Institute1985 - Present
- Principal InvestigatorCardiovascular trials for Westlake Medical Research2010 - 2017
- National Heart, Lung and Blood Institute at the National Institutes of Health (NIH)Intramural (Molecular Diseases/Lipid Metabolism Branch) and extramural (Cardiac Diseases Branch; Division of Heart and Vascular Diseases) divisions1974 - 1977
Professional Memberships
- Member
- Member
External Links
- Websitehttp://www.venturaheart.com
- LinkedIn Publichttp://www.linkedin.com/in/drirvloh
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: